BioLife Solutions (BLFS) News Today

BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month High at $23.32

BioLife Solutions (NASDAQ:BLFS) Trading Up 6%

BNP Paribas Financial Markets increased its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 249.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,515 shares of the medical equipment

TD Cowen boosted their price target on shares of BioLife Solutions from $20.00 to $26.00 and gave the stock a "buy" rating in a research report on Wednesday.

BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month High at $23.25

BioLife Solutions (NASDAQ:BLFS) Trading Down 5.1%

BioLife Solutions (NASDAQ:BLFS) Shares Down 2.5%

Allspring Global Investments Holdings LLC raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 161,879.0% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 131,203 shares of the medical equipment provider's stock after purchas

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been given an average rating of "Buy" by the five research firms that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objecti

BioLife Solutions (NASDAQ:BLFS) Trading 4.9% Higher

BioLife Solutions (NASDAQ:BLFS) Stock Price Down 4.2%

Goldman Sachs Group Inc. lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1,038.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,401,899 shares of the medical equipment provider's stock after b

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 10,000 shares of BioLife Solutions stock in a transaction dated Friday, June 14th. The stock was sold at an average price of $20.18, for a total value of $201,800.00. Following the sale, the chief marketing officer now owns 108,894 shares of the company's stock, valued at approximately $2,197,480.92. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Palisade Capital Management LP trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 11.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,213,334 shares of the medical equipment provider's stock

BioLife Solutions (NASDAQ:BLFS) Trading Down 5.6%

Granahan Investment Management LLC raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 22.8% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,292,675 shares of the medical equipment provider's stock after purchasing an addit

Stephens Inc. AR decreased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 31.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,928 shares of the medical equipment provider's st

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been given an average recommendation of "Buy" by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price targe

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 4,020,000 shares, a growth of 12.9% from the April 30th total of 3,560,000 shares. Based on an average daily volume of 423,600 shares, the short-interest ratio is currently 9.5 days.

Millrace Asset Group Inc. lifted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 116.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 105,643 shares of the medical equipment provider

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 3,560,000 shares, a growth of 14.8% from the April 15th total of 3,100,000 shares. Based on an average trading volume of 390,800 shares, the days-to-cover ratio is currently 9.1 days.

BioLife Solutions (NASDAQ:BLFS) Shares Gap Up to $19.54

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12-month

Benchmark raised shares of BioLife Solutions from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Monday.

Roubaix Capital LLC grew its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 280,337 shares of the medical e

StockNews.com upgraded BioLife Solutions to a "sell" rating in a research note on Friday.

BioLife Solutions (NASDAQ:BLFS - Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.06. The company had revenue of $31.73 million during the quarter, compared to the consensus estimate of $29.30 million. BioLife Solutions had a negative return on equity of 13.36% and a negative net margin of 46.37%. During the same period last year, the business posted ($0.27) EPS.

BioLife Solutions (NASDAQ:BLFS) Trading 15.7% Higher After Earnings Beat

Geneva Capital Management LLC reduced its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 874,485 shares of the medical equipm

Jennison Associates LLC cut its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 90.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 39,978 shares of the medical equipment provider's stock after selling